Skip to main content
VCbacked
Log inGet Started

Ariceum Therapeutics

Berlin, Germany

Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.

$25.0M raised
Apr 2023
Series A
BiotechnologyHealth CareMedicalTherapeutics

Top Investors

Earlybird Venture CapitalAndera PartnersHealthCapEQT Life SciencesPureos Bioventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ariceum Therapeutics

How much funding has Ariceum Therapeutics raised?
Ariceum Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Who are Ariceum Therapeutics's investors?
Ariceum Therapeutics's investors include Earlybird Venture Capital, Andera Partners, HealthCap, EQT Life Sciences, Pureos Bioventures.
Where is Ariceum Therapeutics headquartered?
Ariceum Therapeutics is headquartered in Berlin, Germany.
What does Ariceum Therapeutics do?
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
What stage is Ariceum Therapeutics at?
Ariceum Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ariceum Therapeutics — Funding & Investors." VCBacked, April 18, 2023, https://www.vcbacked.co/company/ariceum-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). Ariceum Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ariceum-therapeutics
Wikipedia (cite web)
{{cite web |title=Ariceum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ariceum-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K